SDC1 and acute kidney injury: Multiple data are invoking the bidirectional relationship between syndecan-1 and kidney dysfunction [7,8]; this hypothesis is gaining ground for two reasons: the importance of glycocalyx injury on the pathophysiology of cardiorenal syndrome is well-known, the second reason is the possibility of using syndecan-1 as a biomarker for early detection of acute kidney injury (AKI).